"121096" . . "CZ - \u010Cesk\u00E1 republika" . . . . . . "1210-7859" . "75/108" . "Adherence k l\u00E9\u010Db\u011B pacient\u016F se schizofreni\u00ED"@cs . "Nonadherence k l\u00E9\u010Db\u011B u pacient\u016F se schizofreni\u00ED je pom\u011Brn\u011B \u010Dast\u00E1 a p\u0159edstavuje z\u00E1va\u017En\u00FD probl\u00E9m. Proto je vhodn\u00E9 ji monitorovat a sna\u017Eit se ji ovlivnit. K monitorov\u00E1n\u00ED se nejl\u00E9pe hod\u00ED m\u011B\u0159en\u00ED hladin antipsychotik v plazm\u011B, proto\u017Ee je relativn\u011B nejp\u0159esn\u011Bj\u0161\u00ED, a tak\u00E9 vzhledem k tomu, \u017Ee u \u0159ady antipsychotik zn\u00E1me jejich optim\u00E1ln\u00ED plazmatick\u00E9 koncentrace. D\u016Fvod\u016F pro nonadherenci existoje mnoho, ovlivnit m\u016F\u017Eeme nejl\u00E9pe ty spjat\u00E9 s l\u00E9ka\u0159i a l\u00E9\u010Dbou. k nim pat\u0159\u00ED zejm\u00E9na \u00FA\u010Dinnost l\u00E9\u010Dby bez ne\u017E\u00E1douc\u00EDch \u00FA\u010Dink\u016F, zvl\u00E1\u0161t\u011B t\u011Bch, kter\u00E9 jsou pro pacienty nep\u0159\u00EDjemn\u00E9 nebo nebezpe\u010Dn\u00E9, pou\u017Eit\u00ED monoterapie, nebo, je-li to nezbytn\u00E9, kombinace antipsychotik \u010Di dal\u0161\u00EDch l\u00E9k\u016F, ov\u0161em za p\u0159edpokladu, \u017Ee zn\u00E1me jejich farmakokinetiku. Dal\u0161\u00EDm d\u016Fle\u017Eit\u00FDm faktorem je tak\u00E9 n\u00E1hled, kter\u00FD bychom se m\u011Bli sna\u017Eit u pacient\u016F vytvo\u0159it, a z\u00EDskat je tak pro spolupr\u00E1ci p\u0159i l\u00E9\u010Db\u011B." . . . . . "2"^^ . "Adherence to the treatment of patients with schizophrenia"@en . . "4"^^ . "Nonadherence k l\u00E9\u010Db\u011B u pacient\u016F se schizofreni\u00ED je pom\u011Brn\u011B \u010Dast\u00E1 a p\u0159edstavuje z\u00E1va\u017En\u00FD probl\u00E9m. Proto je vhodn\u00E9 ji monitorovat a sna\u017Eit se ji ovlivnit. K monitorov\u00E1n\u00ED se nejl\u00E9pe hod\u00ED m\u011B\u0159en\u00ED hladin antipsychotik v plazm\u011B, proto\u017Ee je relativn\u011B nejp\u0159esn\u011Bj\u0161\u00ED, a tak\u00E9 vzhledem k tomu, \u017Ee u \u0159ady antipsychotik zn\u00E1me jejich optim\u00E1ln\u00ED plazmatick\u00E9 koncentrace. D\u016Fvod\u016F pro nonadherenci existoje mnoho, ovlivnit m\u016F\u017Eeme nejl\u00E9pe ty spjat\u00E9 s l\u00E9ka\u0159i a l\u00E9\u010Dbou. k nim pat\u0159\u00ED zejm\u00E9na \u00FA\u010Dinnost l\u00E9\u010Dby bez ne\u017E\u00E1douc\u00EDch \u00FA\u010Dink\u016F, zvl\u00E1\u0161t\u011B t\u011Bch, kter\u00E9 jsou pro pacienty nep\u0159\u00EDjemn\u00E9 nebo nebezpe\u010Dn\u00E9, pou\u017Eit\u00ED monoterapie, nebo, je-li to nezbytn\u00E9, kombinace antipsychotik \u010Di dal\u0161\u00EDch l\u00E9k\u016F, ov\u0161em za p\u0159edpokladu, \u017Ee zn\u00E1me jejich farmakokinetiku. Dal\u0161\u00EDm d\u016Fle\u017Eit\u00FDm faktorem je tak\u00E9 n\u00E1hled, kter\u00FD bychom se m\u011Bli sna\u017Eit u pacient\u016F vytvo\u0159it, a z\u00EDskat je tak pro spolupr\u00E1ci p\u0159i l\u00E9\u010Db\u011B."@cs . "Adherence k l\u00E9\u010Db\u011B pacient\u016F se schizofreni\u00ED" . "Adherence to the treatment of patients with schizophrenia"@en . . "2"^^ . . "\u010Cesk\u00E1 a slovensk\u00E1 neurologie a neurochirurgie" . "Nonadherence to treatment in patients with schizophrenia is a serious problem. It is advisable to monitor. The monitoring is best for measuring plasma levels of antipsychotics. The reasons for nonadherence are many, can affect associated with doctors and treatment. These include the effectiveness of treatment with no side effects, the use of monotherapy or combination antipsychotic drugs. Also important is patient cooperation during treatment."@en . . "Adherence k l\u00E9\u010Db\u011B pacient\u016F se schizofreni\u00ED"@cs . "3" . "[AD8B92F18847]" . "Adherence k l\u00E9\u010Db\u011B pacient\u016F se schizofreni\u00ED" . . . "Ustohal, Libor" . "Vrzalov\u00E1, Michaela" . . "RIV/65269705:_____/12:#0001704" . "P(ED1.1.00/02.0068), V, Z(MSM0021622404)" . . "schizophrenia"@en . "RIV/65269705:_____/12:#0001704!RIV13-MZ0-65269705" .